DULOXETINE\REPAGLINIDE\TICAGRELOR: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
3 (15.0%)
Deaths Reported
8
Hospitalizations
20
As Primary/Secondary Suspect
3
Life-Threatening
Active Ingredient: DULOXETINE HYDROCHLORIDE\REPAGLINIDE\TICAGRELOR ·
First Report: 20221118 · Latest Report: 20241014
What Are the Most Common DULOXETINE\REPAGLINIDE\TICAGRELOR Side Effects?
#1 Most Reported
Hypoglycaemia
7 reports (35.0%)
#2 Most Reported
Acute kidney injury
5 reports (25.0%)
#3 Most Reported
Pancreatitis
4 reports (20.0%)
All DULOXETINE\REPAGLINIDE\TICAGRELOR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypoglycaemia | 7 | 35.0% | 3 | 0 |
| Acute kidney injury | 5 | 25.0% | 2 | 0 |
Who Reports DULOXETINE\REPAGLINIDE\TICAGRELOR Side Effects? Age & Gender Data
Gender: 50.0% female, 50.0% male. Average age: 73.5 years. Most reports from: FR. View detailed demographics →
Is DULOXETINE\REPAGLINIDE\TICAGRELOR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 1 | 0 | 0 |
| 2024 | 14 | 2 | 8 |
What Is DULOXETINE\REPAGLINIDE\TICAGRELOR Used For?
| Indication | Reports |
|---|---|
| Diabetes mellitus | 12 |
| Product used for unknown indication | 7 |
Official FDA Label for DULOXETINE\REPAGLINIDE\TICAGRELOR
Official prescribing information from the FDA-approved drug label.